Bio-Techne Announces Agreement to Acquire ProteinSimple
date:Jun 30, 2014
2014 were $57.1million and Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) were $7.9 million. These figures represent a 30% growth in revenues from the previous same period.

Bio-Techne is a leading developer and manufacturer of purified proteins notably cytokines and growth factors, antibodies, immunoassays and biologically active small molecule compounds which are sold to biomedical researchers and clinical research laboratories. ProteinSimple customers include top ph
5/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/23 07:18